caa a22 4500 606240861 CHVBK 20210128101310.0 cr unu---uuuuu 210128e20150101xx s 000 0 eng 10.1007/s00508-014-0627-0 doi (NATIONALLICENCE)springer-10.1007/s00508-014-0627-0 10th anniversary of the Austrian MDS Platform: aims and ongoing projects [Elektronische Daten] [Sonja Burgstaller, Peter Bettelheim, Otto Krieger, Sigrid Machherndl-Spandl, Thomas Nösslinger, Lisa Pleyer, Heinz Sill, Wolfgang R. Sperr, Reinhard Stauder, Peter Valent, Michael Pfeilstöcker] 10 Jahre MDS Plattform - Ziele und Projekte Summary: The Austrian myelodysplastic syndromes (MDS) Platform was founded as a national working group in 2003 to initiate and coordinate common projects in the field. The incidence of MDS in Austria is approximately 400-500 new MDS cases per year. The overall low number of MDS patients underlines the importance of a national initiative to concentrate knowledge at certain specialized centres, where treatment of these patients mainly takes place. Clinical trials as well as basic research are facilitated by the cooperation of university and non-university hospitals. Other objectives are the generation of therapeutic standards, organization of meetings to spread this information to physicians and patients as well as promoting patient-support groups. Cooperation with international working groups is another important aim of the Platform. The 10th anniversary of the Austrian MDS Platform was organized as a meeting for all interested physicians throughout Austria providing an update on the disease and ongoing projects. Springer-Verlag Wien, 2014 MDS nationallicence Austrian platform meeting nationallicence 10th anniversary nationallicence Österreichisches Plattformtreffen nationallicence 10-Jahres Jubiläum nationallicence Burgstaller Sonja Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria aut Bettelheim Peter Department of Internal Medicine I, Krankenhaus der Elisabethinen, Linz, Austria aut Krieger Otto Department of Internal Medicine I, Krankenhaus der Elisabethinen, Linz, Austria aut Machherndl-Spandl Sigrid Department of Internal Medicine I, Krankenhaus der Elisabethinen, Linz, Austria aut Nösslinger Thomas 3rd Department or Hematology and Oncology, Hanusch Hospital, Vienna, Austria aut Pleyer Lisa 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Hospital Salzburg, Salzburg, Austria aut Sill Heinz Department of Internal Medicine, Division of Hematology, Medical University Graz, Graz, Austria aut Sperr Wolfgang R. Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria aut Stauder Reinhard Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria aut Valent Peter Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria aut Pfeilstöcker Michael 3rd Department or Hematology and Oncology, Hanusch Hospital, Vienna, Austria aut Wiener klinische Wochenschrift Springer Vienna 127/1-2(2015-01-01), 12-15 0043-5325 127:1-2<12 2015 127 508 https://doi.org/10.1007/s00508-014-0627-0 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 review-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s00508-014-0627-0 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Burgstaller Sonja Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria aut NATIONALLICENCE 700 1- Bettelheim Peter Department of Internal Medicine I, Krankenhaus der Elisabethinen, Linz, Austria aut NATIONALLICENCE 700 1- Krieger Otto Department of Internal Medicine I, Krankenhaus der Elisabethinen, Linz, Austria aut NATIONALLICENCE 700 1- Machherndl-Spandl Sigrid Department of Internal Medicine I, Krankenhaus der Elisabethinen, Linz, Austria aut NATIONALLICENCE 700 1- Nösslinger Thomas 3rd Department or Hematology and Oncology, Hanusch Hospital, Vienna, Austria aut NATIONALLICENCE 700 1- Pleyer Lisa 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Hospital Salzburg, Salzburg, Austria aut NATIONALLICENCE 700 1- Sill Heinz Department of Internal Medicine, Division of Hematology, Medical University Graz, Graz, Austria aut NATIONALLICENCE 700 1- Sperr Wolfgang R. Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria aut NATIONALLICENCE 700 1- Stauder Reinhard Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria aut NATIONALLICENCE 700 1- Valent Peter Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria aut NATIONALLICENCE 700 1- Pfeilstöcker Michael 3rd Department or Hematology and Oncology, Hanusch Hospital, Vienna, Austria aut NATIONALLICENCE 773 0- Wiener klinische Wochenschrift Springer Vienna 127/1-2(2015-01-01), 12-15 0043-5325 127:1-2<12 2015 127 508